4//SEC Filing
Eaton Bruce 4
Accession 0001650664-23-000002
CIK 0001650664other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:59 PM ET
Size
5.0 KB
Accession
0001650664-23-000002
Insider Transaction Report
Form 4
Eaton Bruce
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2023-09-06$8.82/sh−103$908→ 75,728 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2023. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001874831
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 4:59 PM ET
- Size
- 5.0 KB